India cracks down on unauthorized sale of GLP-1 weight-loss drugs, intensifies surveillance

In order to ensure ethical pharmaceutical practices in the supply chain of weight-loss drugs (GLP-1), the Drugs Controller of India has intensified regulatory surveillance against their unauthorized sale and promotion.